Badgaiyan, R
Regulatory status: investigational and research-only DSIP is not FDA-approved as a drug
Treatment duration depends on your cognitive goals, baseline function, response to therapy, and whether youre seeking acute enhancement or long-term neurological optimization
Clinical stage: As of now, Cagrilintide is still in Phase II/III trials, with early results showing significant reductions in body weight compared to placebo
This is a key step for understanding the intervention of the compound without interference by the host immune system However, in the DMFA, the leukocytes are not removed, which may partially explain the low MB inhibition profile shown in this assay
BPC-157 is a pentadecapeptide derived from a protective protein found in gastric juice, studied for tissue repair, gut barrier protection, and angiogenesis